US7527783B2ExpiredUtilityPatentIndex 87
Methods for deactivating allergens and preventing disease
Est. expiryMar 23, 2024(expired)· nominal 20-yr term from priority
A61K 33/20A61K 33/00Y02A50/30
87
PatentIndex Score
17
Cited by
29
References
4
Claims
Abstract
This invention relates to articles of manufacture containing liquid compositions of hypohalous acid or hypohalous acid salt for deactivating allergens and preventing diseases on hard surfaces, soft surfaces and in the air. The articles of manufacture contain usage instructions with health claims. This invention also includes methods of instructing the public and promoting the use of these compositions.
Claims
exact text as granted — not AI-modified1. An in vivo test method for testing allergic response in animals,
wherein said test method comprises the subcutaneous injection of allergens that had been treated with a composition selected from a group consisting of a hypohalous acid, a
hypohalous acid salt, and a combination thereof,
wherein said composition has a concentration between 10 and 200 ppm;
wherein said allergen is selected from the group consisting of pollen, mold, pet dander, dust mite, cockroach and mixtures thereof; and
wherein said allergic response is selected from the group consisting of skin rash, hay fever, sneezing, runny nose, red eyes and mixtures thereof.
2. An in vivo test method for testing allergic response in animals,
wherein said test method comprises the subcutaneous injection of allergens that had been treated with a composition selected from a group consisting of a hypohalous acid, a
hypohalous acid salt, and a combination thereof,
wherein said composition has a concentration between 10 and 200 ppm;
wherein said allergen is dust mite; and
wherein said allergic response is sneezing.
3. An in vivo test method for testing allergic response in animals,
wherein said test method comprises the subcutaneous injection of a solution of Aspergillus fumigatus that had been treated with a composition selected from a group consisting of a hypohalous acid, a hypohalous acid salt, and a combination thereof,
wherein said composition has a concentration between 10 and 200 ppm;
wherein said allergic response is selected from the group consisting of skin rash, hay fever, sneezing, runny nose, red eyes and mixtures thereof; and
wherein the subcutaneous injection comprises using a sample from treatment of the solution with the composition for skin prick testing on animals who had a history of positive skin prick.
4. An in-vivo test method for testing an allergic response in animals comprising:
a) treating a solution of Aspergillus fumigatus spores with a composition selected from a group consisting of a hypohalous acid, a hypohalous acid salt, and a combination thereof to form a resulting inactivated Aspergillus fumigatus solution; and
b) testing the in-vivo allergic response of the resulting inactivated Aspergillus fumigatus solution by subcutaneous injection of the resulting inactivated Aspergillus fumigatus solution; and
c) evaluating the resulting subcutaneous injection for the allergic response wherein said allergic response is selected from the group consisting of shin rash, hay fever, sneezing, runny nose, red eyes, and mixtures thereof.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.